The Cooper Companies, Inc.
COO
주식 순위
#1888
The Cooper Companies, Inc. (COO) operates as a global medical device firm,... The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
주가
$58.96
시가총액
$11.21B
변동 (1일)
1.37%
변동 (1년)
-21.38%
국가
US
거래 The Cooper Companies, Inc. (COO)
카테고리
Healthcare
The Cooper Companies, Inc. (COO)의 발행 주식 수
July 2026 기준 발행 주식 수: 193.40M
The Cooper Companies, Inc.의 최신 재무 보고서와 주가에 따르면 현재 발행 주식 수는 193.40M입니다. October 2024 말 기준 회사는 198.90M주를 발행했습니다. 발행 주식 수는 일반적으로 주식 분할이나 자사주 매입에 의해 영향을 받습니다.
The Cooper Companies, Inc. (COO)의 발행 주식 수 기록 (2000 ~ 2026)
매년 말 기준 발행 주식 수
| 연도 | 발행 주식 수 | 변화 |
|---|---|---|
| 2026 (TTM) | 193.40M | -3.30% |
| 2025 | 200.00M | 0.55% |
| 2024 | 198.90M | 0.45% |
| 2023 | 198.00M | 0.41% |
| 2022 | 197.20M | 0.00% |
| 2021 | 197.20M | 0.41% |
| 2020 | 196.40M | -0.41% |
| 2019 | 197.20M | 0.41% |
| 2018 | 196.40M | 0.41% |
| 2017 | 195.60M | 0.82% |
| 2016 | 194.00M | 0.00% |
| 2015 | 194.00M | 0.91% |
| 2014 | 192.24M | -1.14% |
| 2013 | 194.46M | 1.47% |
| 2012 | 191.65M | 2.15% |
| 2011 | 187.62M | 3.02% |
| 2010 | 182.12M | 0.79% |
| 2009 | 180.69M | 0.40% |
| 2008 | 179.98M | 0.64% |
| 2007 | 178.83M | 0.42% |
| 2006 | 178.09M | 7.91% |
| 2005 | 165.03M | 27.07% |
| 2004 | 129.87M | 3.98% |
| 2003 | 124.90M | 2.19% |
| 2002 | 122.23M | 2.98% |
| 2001 | 118.70M | 4.57% |
| 2000 | 113.50M | 0.00% |
유사 기업 또는 경쟁사의 발행 주식 수
| 회사 | 발행 주식 수 | 차이 | 국가 |
|---|---|---|---|
| 354.50M | 83.30% |
US
|
|
| 461.20M | 138.47% |
FR
|
|
| - | - |
JP
|
|
| 274.79M | 42.08% |
US
|
|
| - | - |
CH
|
